| Basics |
| Company: |
AquaBounty Technologies, Inc. |
| IPO Date: |
January 9, 2017 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$2.81M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.14 | 3.91%
|
| Avg Daily Range (30 D): |
$0.03 | 4.67%
|
| Avg Daily Range (90 D): |
$0.04 | 3.90%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.04M |
| Avg Daily Volume (30 D): |
.65M |
| Avg Daily Volume (90 D): |
.23M |
| Trade Size |
| Avg Trade Size (Sh.): |
14 |
| Avg Trade Size (Sh.) (30 D): |
455 |
| Avg Trade Size (Sh.) (90 D): |
428 |
| Institutional Trades |
| Total Inst.Trades: |
125 |
| Avg Inst. Trade: |
$1.52M |
| Avg Inst. Trade (30 D): |
$.52M |
| Avg Inst. Trade (90 D): |
$.52M |
| Avg Inst. Trade Volume: |
.01M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$2.13M |
| Avg Closing Trade (30 D): |
$M |
| Avg Closing Trade (90 D): |
$M |
| Avg Closing Volume: |
21.76K |
|
|
|
|
| News |
May 15, 2024 @ 2:20 PM
AquaBounty Technologies, Inc. (AQB) Reports Q1 Los...
Source: Zacks Equity Research
|
May 14, 2024 @ 1:10 PM
Immunome, Inc. (IMNM) Reports Q1 Loss, Misses Reve...
Source: Zacks Equity Research
|
May 13, 2024 @ 9:10 PM
Cara Therapeutics (CARA) Reports Q1 Loss, Misses R...
Source: Zacks Equity Research
|
May 8, 2024 @ 9:45 PM
Arcus Biosciences, Inc. (RCUS) Reports Q1 Loss, To...
Source: Zacks Equity Research
|
Oct 16, 2023 @ 12:47 PM
Why ContraFect Shares Are Trading Higher By Around...
Source: Lisa Levin
|
| Financials |
| |
TTM |
Q3 2024 |
Q2 2024 |
|
Basic EPS
|
$-19.06
|
$-.88
|
$-13.08
|
|
Diluted EPS
|
$-19.06
|
$-.88
|
$-13.08
|
|
Revenue
|
$ 1.26M
|
$ .05M
|
$ .18M
|
|
Gross Profit
|
$
|
$
|
$
|
|
Net Income / Loss
|
$ -73.5M
|
$ -3.4M
|
$ -50.51M
|
|
Operating Income / Loss
|
$ -71.15M
|
$ -2.36M
|
$ -49.52M
|
|
Cost of Revenue
|
$
|
$
|
$
|
|
Net Cash Flow
|
$ -17.27M
|
$ -.23M
|
$ -2.86M
|
|
PE Ratio
|
|
|
|
| Splits |
| Oct 16, 2023:
20:1
|
| Jan 05, 2017:
30:1
|
|
